Company Legend Biotech Corporation

Equities

LEGN

US52490G1022

Biotechnology & Medical Research

Market Closed - Nasdaq 21:00:00 17/07/2024 BST 5-day change 1st Jan Change
55 USD -1.61% Intraday chart for Legend Biotech Corporation +16.23% -8.59%

Business Summary

Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.

Number of employees: 2,000

Sales per Business

USD in Million2022Weight2023Weight Delta
Novel Cell Therapies
100.0 %
117 100.0 % 285 100.0 % +143.70%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
94.7 %
117 99.7 % 270 94.7 % +131.47%
Europe
5.3 %
0 0.1 % 15 5.3 % +19,993.33%
China
0.1 %
0 0.3 % 0 0.1 % -45.43%

Managers

Managers TitleAgeSince
Chief Executive Officer 51 30/06/19
Director of Finance/CFO 53 31/08/19
Chief Tech/Sci/R&D Officer - 30/04/18
Chief Tech/Sci/R&D Officer - 30/04/19
Chief Tech/Sci/R&D Officer - 28/02/22
Chief Tech/Sci/R&D Officer 46 10/04/23
- -
Investor Relations Contact - 31/12/18
Human Resources Officer - 31/10/19
General Counsel - 30/04/18

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 51 30/06/19
Director/Board Member 67 30/04/20
Director/Board Member 74 22/11/20
Director/Board Member 68 02/12/20
Chief Executive Officer 59 26/05/15
Director/Board Member 68 01/08/22
Director/Board Member 55 30/04/15
Director/Board Member 48 30/04/20
Director/Board Member 62 30/04/20
Director/Board Member 67 01/08/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 364,566,989 360,183,848 ( 98.80 %) 0 98.80 %

Shareholders

NameEquities%Valuation
Fidelity Management & Research Co. LLC
8.876 %
16,147,032 8.876 % 715 M $
T. Rowe Price International Ltd.
6.019 %
10,949,120 6.019 % 485 M $
RA Capital Management LP
3.772 %
6,861,097 3.772 % 304 M $
HHLR Advisors Ltd. (Cayman Islands)
3.290 %
5,984,550 3.290 % 265 M $
BlackRock Advisors LLC
2.287 %
4,159,952 2.287 % 184 M $
Wellington Trust Co., NA
1.437 %
2,614,423 1.437 % 116 M $
Capital Research & Management Co. (World Investors)
1.312 %
2,385,960 1.312 % 106 M $
Westfield Capital Management Co. LP
1.231 %
2,239,774 1.231 % 99 M $
Capital Research & Management Co. (International Investors)
1.199 %
2,181,074 1.199 % 97 M $
Janus Henderson Investors US LLC
1.109 %
2,018,238 1.109 % 89 M $
NameEquities%Valuation
174,497,556 60.32 % 3 864 M $
Aquapoint LP
10.47 %
30,300,000 10.47 % 671 M $
1,067,386 0.3690 % 24 M $
Ying Huang
0.0444 %
128,492 0.0444 % 3 M $
28,885 0.009986 % 639 658 $
Patrick Casey
0.008758 %
25,334 0.008758 % 561 021 $
Xiao Hui Ji
0.006370 %
18,427 0.006370 % 408 066 $
Lori Macomber
0.003892 %
11,258 0.003892 % 249 308 $
Li Mao
0.002397 %
6,934 0.002397 % 153 553 $
4,070 0.001407 % 90 130 $

Company contact information

Legend Biotech Corp.

2101 Cottontail Lane

08873, Somerset

+732 317 5050

http://www.legendbiotech.com
address Legend Biotech Corporation(LEGN)
  1. Stock Market
  2. Equities
  3. LEGN Stock
  4. Company Legend Biotech Corporation